Odyssean »

Apex Technology Acqui-cl A shares owned by Odyssean

Quarter-by-quarter ownership of Apex Technology Acqui-cl A (AVPT) shares owned by Odyssean from 13F filings

Historical chart of Odyssean investment in Apex Technology Acqui-cl A

Tip: Access up to 7 years of quarterly data

All positions including Apex Technology Acqui-cl A held by Odyssean consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apex Technology Acqui-cl A by Odyssean

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.1M 274k 11.21

More positions owned by Odyssean

Ultragenyx Pharmaceutical (RARE)
Kymera Therapeutics (KYMR)
Ideaya Biosciences (IDYA)
Vaxcyte (PCVX)
Affirm Hldgs Com Cl A (AFRM)
Celldex Therapeutics Com New (CLDX)
Loar Holdings Com Shs (LOAR)
Mirum Pharmaceuticals (MIRM)
Doordash Cl A (DASH)
Krystal Biotech (KRYS)
Viking Holdings Ord Shs (VIK)
Medpace Hldgs (MEDP)
Toast Cl A (TOST)
American Healthcare Reit Com Shs (AHR)
Nicolet Bankshares (NIC)

View all positions for Odyssean

Top funds holding Apex Technology Acqui-cl A

Anchor @ 65 Pte
BlackRock
Vanguard Portfolio Management
Morgan Stanley
Vanguard Capital Management
Goldman Sachs Group
D. E. Shaw & Co
Parsifal Capital Management
Geode Capital Management
State Street Corporation
Two Sigma Investments
Dimensional Fund Advisors
Healthcare Of Ontario Pension Plan Trust Fund
Jennison Associates
SG Americas Securities

View all funds holding Apex Technology Acqui-cl A